Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VST with Alloderm vs CTG in Immediate Implants
NCT06241196Phase 2Active, not recruiting
- Sponsor
- Tanta University
- Start
- Jul 2022
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Tanta University. Primary endpoints: Changes in peri-implant mucosal level at 12 months and Changes in gingival phenotype at 12 months. Started Jul 2022; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06241196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06241196.